Leishmaniasis, an emerging infection in travelers

International Journal of Infectious Diseases

Volumn 14, Issue 12, 2010, Pages

  Pavli, Androula ^a   Maltezou, Helena C ^a  

^a Hellenic Center for Disease Control and Prevention   (Greece)

Author keywords

Cutaneous; Imported disease; Leishmaniasis; Pre travel advice; Travelers; Visceral

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; AZITHROMYCIN; FLUCONAZOLE; IMIQUIMOD; MEGLUMINE ANTIMONATE; MILTEFOSINE; PENTAMIDINE; STIBOGLUCONATE SODIUM;

AMINOTRANSFERASE BLOOD LEVEL; CHILL; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DIARRHEA; DIFFERENTIAL DIAGNOSIS; FEVER; GASTROINTESTINAL TOXICITY; HEADACHE; HEART ARRHYTHMIA; HUMAN; HYPERGLYCEMIA; HYPOKALEMIA; INFECTION PREVENTION; LEISHMANIA; MOTION SICKNESS; NAUSEA; NEPHROTOXICITY; PANCREATITIS; PNEUMONIA; REVIEW; SIDE EFFECT; SKIN LEISHMANIASIS; TERATOGENICITY; TRAVEL; VISCERAL LEISHMANIASIS; VOMITING;

ANIMALS; COMMUNICABLE DISEASES, EMERGING; HUMANS; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; PSYCHODIDAE; TRAVEL;

EID: 78649634790     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2010.06.019     Document Type: Review

References (83)

1. Maltezou H.C. Leishmaniasis. Tropical and emerging infectious diseases 2010, 163-185. Research Signpost, Kerala, India. H.C. Maltezou, A. Gikas (Eds.).
2. Pérez-Ayala A., Norman F., Pérez-Molina J.A., Herrero J.M., Monge B., López-Vélez R. Imported leishmaniasis, a heterogeneous group of diseases. J Travel Med 2009, 16:395-401.
3. Kafetzis D.A., Maltezou H.C. Visceral leishmaniasis in paediatrics. Curr Opin Infect Dis 2002, 15:289-294.
4. Maltezou H.C., Siafas C., Mavrikou M., Spyridis P., Stavrinadis C., Karpathios T., et al. Visceral leishmaniasis during childhood in Southern Greece. Clin Infect Dis 2000, 31:1139-1143.
5. Dujardin J.C., Campino L., Capavate C., Dedet J.P., Gradoni L., Soteriadou K., et al. Spread of vector-borne diseases and neglect of leishmaniasis, Europe. Emerg Infect Dis 2008, 14:1013-1018.
6. Sutherst R.W. Global change and human vulnerability to vector-borne diseases. Clin Microbiol Rev 2004, 17:136-173.
7. Maltezou H.C. Drug resistance in visceral leishmaniasis. J Biomed Biotechnol 2010, 2010:617521.
8. Alvar J., Aparicio P., Aseffa A., Den Boer M., Canavate C., Dedet J.P., et al. The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev 2008, 21:334-359.
9. World Tourism Organization. Tourism 2020 vision. Available at: (accessed September 17, 2010). http://www.world-tourism.org/.
10. Travel Industry Association. Travel market segments. Available at: (accessed September 17, 2010). http://www.ustravel.org/research/international-research.
11. Antinori S., Gianelli E., Calattini S., Longhi E., Gramiccia M., Corbellino M. Cutaneous leishmaniasis: an increasing threat for travelers. Clin Microbiol Infect 2005, 11:343-346.
12. Caumes E., Carriere J., Guermonprez G., Bricaire F., Danis M., Gentilini M. Dermatoses associated with travel to tropical countries: a prospective study of the diagnosis and management of 269 patients presenting to a tropical disease unit. Clin Infect Dis 1995, 20:542-548.
13. Lawn S.D., Whetham J., Chiodini P.L., Kanagalingham J., Whatson J., Behrens R.H., et al. New world mucosal and cutaneous leishmaniasis: an emerging health problem among British travellers. QJM 2004, 97:781-788.
14. Morizot G., Delgiudice P., Caumes E., Laffitte E., Marty P., Dupuy A., et al. Healing of Old World cutaneous leishmaniasis in travelers treated with fluconazole: drug effect or spontaneous evolution?. Am J Trop Med Hyg 2007, 76:48-52.
15. Stark D., van Hal S., Lee R., Marriott D., Harkness J. Leishmaniasis, an emerging imported infection: report of 20 cases from Australia. J Travel Med 2008, 15:351-354.
16. Malik A.N., John L., Bryceson A.D., Lockwood D.N. Changing pattern of visceral leishmaniasis, United Kingdom, 1985-2004. Emerg Infect Dis 2006, 12:1257-1259.
17. Herwald B.L., Stokes S.L., Juranek D.D. American cutaneous leishmaniasis in U.S. travelers. Ann Intern Med 1993, 118:779-784.
18. Centers for Disease Control and Prevention. Update: cutaneous leishmaniasis in U.S. military personnel-Southwest/Central Asia, 2002-2004. MMWR Morb Mortal Wkly Rep 2004; 53:264-5.
19. Ahluwalia S., Lawn S.D., Kanagalingam J., Grant H., Lockwood D.N. Mucocutaneous leishmaniasis: an imported infection among travelers to Central and South America. Br Med J 2004, 329:842-844.
20. Harms G., Schönian G., Feldmeier H. Leishmaniasis in Germany. Emerg Infect Dis 2003, 9:873-875.
21. El Hajj Thellier M., Carriere J., Bricaire F., Danis M., Caumes E. Localized cutaneous leishmaniasis imported into Paris: a review pf 39 cases. Int J Dermatol 2004, 43:120-125.
22. Scarisbrick J., Chiodini P., Watson J., Moody A., Armstrong M., Lockwood D., et al. Clinical features and diagnosis of 42 travellers with cutaneous leishmaniasis. Travel Med Infect Dis 2006, 4:14-21.
23. Delgado O., Silva S., Coraspe V., Rivas M.A., Rodriguez-Morales A.J., Navarro P., et al. Cutaneous leishmaniasis imported from Colombia to Northcentral Venezuela: implications for travel advice. Travel Med Infect Dis 2008, 6:376-379.
24. Berens-Riha N., Fleischmann E., Pratlong E., Bretzel G., von Sonnenburg F., Löscher T. Cutaneous leishmaniasis (Leishmania tropica) in a German tourist after travel to Greece. J Travel Med 2009, 16:220-222.
25. Joseph M., Soong V., Soong L. Leishmania mexicana infection of the eyelid in a traveler to Belize. Braz J Infect Dis 2007, 11:149-152.
26. Haider S., Boutross-Tadross O., Radhi J., Momar N. Cutaneous ulcer in a man returning from central America. CMAJ 2003, 168:590-591.
27. Scope A., Trau H., Bakon M., Yarom N., Nasereddin A., Schwartz E. Imported mucosal leishmaniasis in a traveler. Clin Infect Dis 2003, 37:e83-e86.
28. Weitzel T., Mühlberger N., Jelinek T., Schunk M., Ehrhardt, Bogdan C., et al. Imported leishmaniasis in Germany 2001-2004: data of the SIMPID surveillance network. Eur J Clin Microbiol Infect Dis 2005, 24:471-476.
29. Ju O., Grove D.I., Jaksic W.J., Dart G.W. Visceral leishmaniasis: a trip to the Greek Islands is not always idyllic. Med J Aust 2004, 181:446-447.
30. Army Medical Surveillance Activity (AMSA). Leishmaniasis in relation to service in Iraq/Afghanistan, U.S. Armed Forces, 2001-2006. Medical Surveillance Monthly Report 2007; 14:2-5.
31. Woodrow J.P., Hartzell J.D., Czarnik J., Brett-Major D.M., Wortmann G. Cutaneous and presumed visceral leishmaniasis in a soldier deployed to Afghanistan. MedGenMed 2006, 8:43.
32. Centers for Disease Control and Prevention. Viscerotropic leishmaniasis in persons returning from Operation Desert Storm-1990--1991. MMWR Morb Mortal Wkly Rep 1992; 41:131-4.
33. Centers for Disease Control and Prevention. Cutaneous leishmaniasis in U.S. military personnel-Southwest/Central Asia, 2002-2003. MMWR Morb Mortal Wkly Rep 2003; 52;1009-12.
34. Centers for Disease Control and Prevention. Two cases of visceral leishmaniasis in U.S. military personnel-Afghanistan, 2002-2004. MMWR Morb Mortal Wkly Rep 2004; 53:265-8.
35. Willard R.J., Jeffcoat A.M., Benson P.M., Walsh D.S. Cutaneous leishmaniasis in soldiers from Fort Campell, Kentucky returning from Operation Iraqi Freedom highlights diagnostic and therapeutic options. J Am Acad Dermatol 2005, 52:977-987.
36. Bezold G., Lange M., Gethöffer K., Pillekamp H., Reindl H., Richter C., et al. Competitive polymerase chain reaction used to diagnose cutaneous leishmaniasis in German soldiers infected during military exercises in French Guiana. Eur J Clin Microbiol Infect Dis 2001, 6:421-424.
37. Scope A., Trau H., Anders G., Barzilai A., Confino Y., Schwartz E. Experience with New World cutaneous leishmaniasis in travelers. J Am Acad Dermatol 2003, 49:672-678.
38. Solomon M., Baum S., Barzilai A., Scope A., Trau H., Schwartz E. Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis. J Am Acad Dermatol 2007, 56:612-616.
39. Zlotogorski A., Gilead L., Jonas F., Horev L., Klaus S.N. South American cutaneous leishmaniasis: report of ten cases in Israeli travelers. J Eur Acad Dermatol Venereol 1998, 11:32-36.
40. Freedman D.O., Weld L.H., Kozarsky P.E., Fisk T., Robins R., von Sonnenburg F., et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 2006, 354:119-130.
41. Bauer I.L. Knowledge and behavior of tourists to Manu National Park, Peru, in relation to leishmaniasis. J Travel Med 2002, 9:173-179.
42. Kiiamov F.A., Orlova L.S., Topchin IuA, Shalabaev G.A. Cases of cutaneous leishmaniasis infection resulting from the importation of sandflies via transportation means. Med Parazitol 1990, 6:40-41.
43. Rotureau B., Ravel C., Aznar C., Carme B., Detet J.P. First report of Leishmania infantum in French Guiana: canine visceral leishmaniasis imported from the Old World. J Clin Microbiol 2006, 44:1120-1122.
44. Magill A.J., Grogl M., Gasser R.A., Sun W., Oster C.N. Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med 1993, 328:1383-1387.
45. Ritmeijer K., Dejenie A., Assefa Y., Hundie T.B., Mesure J., Boots G., et al. A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection. Clin Infect Dis 2006, 43:357-364.
46. Molina I., Falco V., Crespo M., Riera C., Ribera E., Curran A., et al. Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients. J Antimicrob Chemother 2007, 60:837-842.
47. Schwartz E., Hatz C., Blum J. New World cutaneous leishmaniasis in travellers. Lancet Infect Dis 2006, 6:342-349.
48. Akilov O.E., Khachemoune A., Hasan T. Clinical manifestations and classification of Old World cutaneous leishmaniasis. Int J Dermatol 2007, 46:132-142.
49. Ryan E.T., Wilson M.E., Kain K.C. Illness after international travel. N Engl J Med 2002, 347:505-516.
50. Nirwan P.S., Rastogi V. Cutaneous leishmaniasis: an emerging infection in a non endemic area and a brief update. Indian J Med Microbiol 2007, 25:272-275.
51. Calvopina M., Gomez E.A., Sindermann H., Cooper P.J., Hashiguchi Y. Relapse of New World diffuse cutaneous leishmaniasis caused by Leishmania mexicana after miltefosine treatment. Am J Trop Med Hyg 2006, 75:1074-1077.
52. Rhajaoui M., Nasereddin A., Fellah H., Azmi K., Amir F., Jawabreh A.A., et al. New clinicoepidemiologic profile of cutaneous leishmaniasis, Morocco. Emerg Infect Dis 2007, 13:1358-1360.
53. Markle M.H., Markhoul K. Cutaneous leishmaniasis: recognition and treatment. Am Pharm Physician 2004, 69:1455-1460.
54. Boelaert M., Bhattacharya S., Chappuis F., El Safi S.H., Hailu A., Mondal D., et al. Evaluation of rapid diagnostic tests: visceral leishmaniasis. Nat Rev Microbiol 2007, 5:S30-S37.
55. Van der Meide W., Guerra J., Schoone G., Farenhorst M., Coelho L., Faber W., et al. Comparison between quantitative nucleic acid sequence-based amplification, real-time reverse transcriptase PCR, and real-time PCR for quantification of Leishmania parasites. J Clin Microbiol 2008, 46:73-78.
56. Reithinger R., Dujardin J.C., Hechmi L., Pirmez C., Alexander B., Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis 2007, 7:581-596.
57. Maltezou H.C. Visceral leishmaniasis: advances in treatment. Recent Pat Antiinfect Drug Discov 2008, 3:192-198.
58. Blum J.A., Hatz C.F. Treatment of cutaneous leishmaniasis in travelers. J Travel Med 2009, 16:123-131.
59. Raguenaud M.E., Jansson A., Vanlerberghe V., Van der Auwera G., Deborggraeve S., Dujardin J.C., et al. Epidemiology and clinical features of patients with visceral leishmaniasis treated by MSF clinic in Bakool region, Somalia, 2004-2006. PLoS Negl Trop Dis 2007, 1:e85.
60. Minodier P., Piarroux R., Garnier J.M., Unal D., Perrimond H., Dumon H. Pediatric visceral leishmaniasis in southern France. Pediatr Infect Dis J 1998, 17:701-704.
61. Sundar S., Chakravarty J., Rai V.K., Agrawal N., Singh S.P., Chauhan V. Amphotericin B treatment for Indian visceral leishmaniasis: response to 15 daily versus alternate-day infusions. Clin Infect Dis 2007, 45:556-561.
62. Olliaro P.L., Guerin P.J., Gerstl S., Aga-Haaskjold A., Rottingen J.A., Shyan S. Treatment options for visceral leishmaniasis: a systemic review of clinical studies done in India, 1980-2004. Lancet Infect Dis 2005, 5:763-774.
63. Sundar S., Jha T.K., Thakur C.P., Sinha P.K., Bhattacharya S.K. Injectable paromomycin for visceral leishmaniasis in India. N Engl J Med 2007, 356:2571.
64. Bhattacharya S.K., Sinha P.K., Sundar S., Thakur C.P., Jha T.K., Pandey K., et al. Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis. J Infect Dis 2007, 196:591-598.
65. Naafs B. Pentamidine induced diabetes mellitus. Trans R Soc Trop Med Hyg 1985, 79:141.
66. Sundar S., Jha T.K., Thakur C.P., Bhattacharya S.K., Rai M. Oral miltefosine for the treatment of Indian visceral leishmaniasis. Trans R Soc Trop Med Hyg 2006, 100(Suppl 1):S26-33.
67. Soto J., Berman J. Treatment of New World cutaneous leishmaniasis with miltefosine. Trans R Soc Trop Med Hyg 2006, 100(Suppl 1):S34-40.
68. Alrajhi A.A., Ibrahim E.A., De Vol E.B., Khairat M., Faris R.M., Maguire J.H. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med 2002, 346:891-895.
69. Soto J., Rea J., Balderrama M., Toledo J., Soto P., Valda L., Berman J.D. Efficacy of miltefosine for Bolivian cutaneous leishmaniasis. Am J Trop Med Hyg 2008, 78:210-211.
70. Teixeira A.C., Paes M.G., Guerra Jde O., Prata A., Silva-Vergara M.L. Low efficacy of azithromycin to treat cutaneous leishmaniasis in Manaus, AM, Brazil. Rev Inst Med Trop Sao Paulo 2007, 49:235-238.
71. Silva-Vergara M.L., Silva Lde A., Maneira F.R., da Silva A.G., Prata A. Azithromycin in the treatment of mucosal leishmaniasis. Rev Inst Med Trop Sao Paulo 2004, 46:175-177.
72. Amato V., Amato J., Nicodemo A., Uip D., Amato-Neto V., Duarte M. Treatment of mucocutaneous leishmaniasis with pentamidine isothionate. Ann Dermatol Venereol 1998, 125:492-495.
73. Krolewiecki A.J., Romeo H.D., Cajal S.P., Abraham D., Mimori T., Mastumoto T., et al. A randomized clinical trial comparing oral azithromycin and meglumine antimoniate for the treatment of American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis. Am J Trop Med Hyg 2007, 77:640-646.
74. Tuon F.F., Amato V.S., Graft M.E., Siqueira A.M., Nicodemo A.C., Neto V.A. Treatment of New World cutaneous leishmaniasis-systemic review with a meta-analysis. Int J Dermatol 2008, 47:109-124.
75. Amato V.S., Tuon F.F., Siqueira A.M., Nicodemo A.C., Neto V.A. Treatment of mucosal leishmaniasis in Latin America: systemic review. Am J Trop Med Hyg 2007, 77:266-274.
76. Lessa H.A., Machado P., Lima F., Cruz A.A., Bacellar O., Guerreiro J., Carvalho E.M. Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony. Am J Trop Med Hyg 2001, 65:87-89.
77. Sadeghian G., Niforoushzadeh M.A. Effect of combination therapy with systemic Glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis. Int J Dermatol 2006, 45:819-821.
78. Junaid A.J. Treatment of cutaneous leishmaniasis with infrared heat. Int J Dermatol 1986, 25:470-472.
79. Al Majali O., Routh H.B., Abuloham O., Bhowmik K.R., Muhsen M., Hebeheba H. A 2-year study of liquid nitrogen therapy in cutaneous leishmaniasis. Int J Dermatol 1997, 36:460-462.
80. Asilian A., Sharif A., Faghihi G., Enshaeieh S.H., Shariati F., Siadat A.H. Evaluation of CO laser efficacy in the treatment of cutaneous leishmaniasis. Int J Dermatol 2004, 43:736-738.
81. Asilian A., Sadeghinia A., Faghihi G., Momeni A. Comparative study of the efficacy of combined cryotherapy and meglumine antimoniate (Glucantime) vs cryotherapy and meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis. Int J Dermatol 2004, 43:281-283.
82. Wortmann G.W., Aronson N.E., Miller R.S., Blazes D., Oster C.N. Cutaneous leishmaniasis following local trauma: a clinical pearl. Clin Infect Dis 2000, 31:199-201.
83. Kroeger A., Avila E.V., Morison L. Insecticide impregnated curtains to control domestic transmission of cutaneous leishmaniasis in Venezuela: cluster randomised trial. Br Med J 2002, 325:810-813.